Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Covid-19 | D000086382 | — | U07.1 | 1 | 2 | 1 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Respiratory tract infections | D012141 | — | J06.9 | 1 | 1 | — | — | — | 1 |
Infections | D007239 | EFO_0000544 | — | 1 | 1 | — | — | — | 1 |
Drug-related side effects and adverse reactions | D064420 | — | T88.7 | 1 | 1 | — | — | — | 1 |
Communicable diseases | D003141 | — | — | 1 | 1 | — | — | — | 1 |
Virus diseases | D014777 | — | B34 | 1 | 1 | — | — | — | 1 |
Rna virus infections | D012327 | — | — | 1 | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Sars-cov-2 | D000086402 | — | — | 1 | — | — | — | — | 1 |
Drug common name | Abdavomeran |
INN | abdavomeran |
Description | Abdavomeran is an unknown pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Unknown |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL4650454 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | JV8KBX6XZG (ChemIDplus, GSRS) |